Pick your branch — the sixteen divisions
Circles are the divisions; the branch pages gather every section under one division — open one from a shelf heading below.
EAES-SAGES Clinical Practice Guideline Update: Multi-Society Recommendations on Key Controversies in the Management of Diverticular Disease
A multi-society update on the key controversies in diverticular disease: no routine antibiotics for uncomplicated diverticulitis, elective resection for persistent symptoms after recurrent episodes or recovery from a first abscess, and no routine follow-up colonoscopy after a first uncomplicated episode.
2026 Update · European Association for Endoscopic Surgery (EAES) and SAGES, with AAST, CSSANZ, EAST, ESCP, UEG and WSES participation
2022 Peritoneal Surface Oncology Group International Consensus on HIPEC Regimens for Peritoneal Malignancies: Colorectal Cancer
The 2022 PSOGI consensus on HIPEC for colorectal peritoneal metastases: after complete cytoreductive surgery, HIPEC is conditionally recommended despite the negative PRODIGE-7 results — with short-duration high-dose oxaliplatin strongly rejected and mitomycin-C weakly favoured.
2022 Consensus · Peritoneal Surface Oncology Group International (PSOGI)
INDEPSO-ISPSM Consensus on Peritoneal Malignancies: Management of Colorectal Peritoneal Metastases
The INDEPSO-ISPSM consensus on colorectal peritoneal metastases, written for Indian epidemiology and access: cytoreductive surgery for selected isolated or resectable disease, adjuvant systemic chemotherapy after CRS, and HIPEC outside trials only selectively — particularly at PCI 11–15.
2024 · Indian Network for Development of Peritoneal Surface Oncology (INDEPSO) and Indian Society of Peritoneal Surface Malignancies (ISPSM)
Multi-Society Guideline on Cytoreductive Surgery and HIPEC: Methodology and Overview of the Results
The multi-society CRS/HIPEC guideline's methodology and overview paper: seven recommendations built by GRADE ADOLOPMENT — conditional for metachronous colorectal and gastric peritoneal metastases, strong for pseudomyxoma, peritoneal mesothelioma and advanced ovarian cancer after neoadjuvant chemotherapy.
2024 · PSOGI with the European Society of Surgical Oncology, ERN-EURACAN, the Society of Surgical Oncology and partner societies (14 countries)
No guideline cards in this division yet — the next intake tiers convert division by division, and empty shelves stay empty until then.
No guideline cards in this division yet — the next intake tiers convert division by division, and empty shelves stay empty until then.
No guideline cards in this division yet — the next intake tiers convert division by division, and empty shelves stay empty until then.
Diagnosis and Treatment of Acute Appendicitis: 2025 Edition of the World Society of Emergency Surgery Jerusalem Guidelines
The 2025 Jerusalem update for acute appendicitis: 35 GRADE recommendations over 19 questions — risk scores and imaging first, antibiotics alone only for selected uncomplicated cases, laparoscopic appendectomy as the standard operation, and 2–3 days of postoperative antibiotics in complicated disease.
2025 Edition · World Society of Emergency Surgery (WSES)
Guideline for the Diagnosis and Treatment of Appendicitis
SAGES' guideline for the diagnosis and treatment of appendicitis: imaging first, operative management suggested for both uncomplicated and complicated adult disease, flexible timing, and interval appendectomy after successful nonoperative treatment of complicated disease.
2023 · Society of American Gastrointestinal and Endoscopic Surgeons (SAGES)
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
The 2021 Surviving Sepsis Campaign guideline for adults with sepsis or septic shock: immediate resuscitation, early antimicrobials and source control, an initial MAP target of 65 mmHg on vasopressors, and norepinephrine as the first-line vasopressor.
2021 · Surviving Sepsis Campaign — Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM)
The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition, 2023
The sixth European guideline on major bleeding and coagulopathy after trauma: early repeated haemostasis monitoring, tranexamic acid as soon as possible and within 3 hours (1 g over 10 minutes, then 1 g over 8 hours), and rapid haemorrhage control.
Sixth Edition, 2023 · Multidisciplinary European Task Force (ESAIC, ESICM, European Shock Society, ESTES, EuSEM and NATA)
Joint Trauma System Damage Control Resuscitation Clinical Practice Guideline, 2019 with June/August 2023 updates
The Joint Trauma System damage-control resuscitation CPG for massively haemorrhaging combat casualties: haemorrhage control first, whole blood or balanced components over crystalloid, early calcium, and — since the June 2023 update — a 2-g tranexamic acid bolus as close to injury as possible.
2019, with June/August 2023 updates · Joint Trauma System, Defense Health Agency / US military
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
The 2021 Surviving Sepsis Campaign guideline (Domain 14 filing) — superseded by the 2026 edition per this record: immediate treatment, cultures before antimicrobials where feasible, an initial 30 mL/kg crystalloid for hypoperfusion with reassessment, and norepinephrine first-line.
2021 · Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM)
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026
The 2026 Surviving Sepsis Campaign guideline for adults with sepsis or septic shock: NEWS/NEWS2, MEWS or SIRS rather than qSOFA alone for hospital screening, early cultures and lactate, at least 30 mL/kg crystalloid in the first 3 hours for hypoperfusion — calculated thoughtfully, with frequent reassessment.
2026 · SCCM and ESICM (international joint guideline)
ESPEN practical and partially revised guideline: Clinical nutrition in the intensive care unit
ESPEN's practical ICU nutrition guideline: assess nutritional risk, prefer early oral or enteral feeding when feasible, individualise parenteral nutrition, use indirect calorimetry where available, and approach energy and protein targets progressively rather than forcing full targets early.
2023 (practical, partially revised) · European Society for Clinical Nutrition and Metabolism (ESPEN)
Guidelines for the provision of nutrition support therapy in the adult critically ill patient: The American Society for Parenteral and Enteral Nutrition
ASPEN's 2022 nutrition support guideline for the adult critically ill patient: because no consistent outcome differences were found, prescribe energy cautiously at 12–25 kcal/kg/day, favour enteral nutrition when feasible, and assume no advantage for exclusive or supplemental parenteral nutrition or higher doses.
2022 · American Society for Parenteral and Enteral Nutrition (ASPEN)
No guideline cards in this division yet — the next intake tiers convert division by division, and empty shelves stay empty until then.
No guideline cards in this division yet — the next intake tiers convert division by division, and empty shelves stay empty until then.
UKKA Clinical Practice Guideline: Vascular Access for Haemodialysis (April 2023)
UKKA's vascular access guideline for haemodialysis: early education and vein preservation, referral and fistula formation for people likely to start haemodialysis within 12 months (2C), combined clinical and ultrasound assessment, and treatment of clinically significant stenosis with dysfunction (1B).
April 2023 · UK Kidney Association (UKKA)
Guidelines on vascular access for hemodialysis from the Brazilian Society of Angiology and Vascular Surgery (20 October 2023)
The SBACV guideline on vascular access for hemodialysis, answering fourteen practical questions: native arteriovenous fistula generally preferred but selection individualised, duplex mapping when examination cannot predict anatomy, and no evidence-supported universal minimum vessel diameter (2C).
2023 · Sociedade Brasileira de Angiologia e de Cirurgia Vascular (SBACV)
Expert consensus on the establishment and maintenance of native arteriovenous fistula (16 June 2021)
The Chinese expert consensus on native arteriovenous fistula: after evaluation and planning, native AVF should generally be the first choice — covering preoperative assessment, vessel planning, operative technique, perioperative drugs and postoperative maintenance, with decisions individualised to local circumstances.
2021 · Expert Group of the Nephrology Branch of the China Academy of Chronic Disease Urology Nephrology and Blood Purification Commission of the China Medical Education Association
No guideline cards in this division yet — the next intake tiers convert division by division, and empty shelves stay empty until then.
2022 ASMBS and IFSO Indications for Metabolic and Bariatric Surgery
The 2022 ASMBS/IFSO indications for metabolic and bariatric surgery: recommended at BMI above 35 kg/m² regardless of comorbidity, to be considered at BMI 30–34.9 kg/m² with metabolic disease, with lower thresholds for Asian populations.
2022 · American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO)
2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery
The 2022 ASMBS/IFSO indications statement (Domain 09 filing of the same guideline as the Domain 02 record): metabolic and bariatric surgery recommended at BMI above 35 kg/m², to be considered at BMI 30–34.9 kg/m² with metabolic disease, with adjusted Asian thresholds.
2022 · American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO)
Scientific Evidence for the Updated Guidelines on Indications for Metabolic and Bariatric Surgery (IFSO/ASMBS)
The 2024 evidence update behind the ASMBS/IFSO indications: a systematic report on 13 criteria — BMI thresholds, Asian populations, diabetes, age, adolescents, safety and long-term outcomes — finding the evidence for expanded eligibility strengthened, though several questions rest on observational data.
2024 Evidence Update · International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) and ASMBS
NICE NG246 (England and Wales-facing national guidance)
NICE guideline NG246 on overweight and obesity: specialist multidisciplinary assessment first, bariatric surgery considered inside the defined NHS pathway after appropriate assessment and prior weight-management approaches, with lower BMI thresholds for several ethnic groups.
NG246 — 2025 (updated 2026) · National Institute for Health and Care Excellence (NICE)
No guideline cards in this division yet — the next intake tiers convert division by division, and empty shelves stay empty until then.
No guideline cards in this division yet — the next intake tiers convert division by division, and empty shelves stay empty until then.
No guideline cards in this division yet — the next intake tiers convert division by division, and empty shelves stay empty until then.
No guideline cards in this division yet — the next intake tiers convert division by division, and empty shelves stay empty until then.
No guideline cards in this division yet — the next intake tiers convert division by division, and empty shelves stay empty until then.
Filing note: two intake records are deliberate duplicate filings of one guideline (the ASMBS/IFSO 2022 indications, filed under Domains 02 and 09; and SSC 2021, filed under Domains 01 and 14 with different statuses) — each record carries its own card, and the duplication is named on the cards themselves. The WSES appendicitis card is the format’s reference card, converted as Tier-1 record Q001.